China SXT Pharmaceuticals, Inc. (SXTC) stock
SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
$3.00+0.27 (+9.89%)
Close on Nov 13, 2026Market cap $2.87MP/E –Yield –
China SXT Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
China SXT Pharmaceuticals's total assets was $34.75M at Mar 31, 2026. For fiscal 2026 it was $34.75M, up 60.4% from the year before. The highest annual figure on record is $34.75M in fiscal 2026.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $34.75M | +60.4% |
| FY2025 | Mar 31, 2025 | $21.66M | -6.3% |
| FY2024 | Mar 31, 2024 | $23.13M | -21.7% |
| FY2023 | Mar 31, 2023 | $29.55M | -11.9% |
| FY2022 | Mar 31, 2022 | $33.55M | -2.9% |
| FY2021 | Mar 31, 2021 | $34.55M | +59.2% |
| FY2020 | Mar 31, 2020 | $21.70M | +24.2% |
| FY2019 | Mar 31, 2019 | $17.47M | +128.1% |
| FY2018 | Mar 31, 2018 | $7.66M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $34.75M | +50.3% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $26.35M | +80.7% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $21.66M | -26.7% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $31.00M | +39.7% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $23.13M | -31.1% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $14.59M | -35.7% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $29.55M | -14.5% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $22.18M | -7.7% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $33.55M | +54.6% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $22.67M | -1.6% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $34.55M | +97.7% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $24.04M | +214.0% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $21.70M | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $23.05M | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $17.47M | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $7.66M | – |
See a number that looks wrong?